Actos 15 mg Tablets (Pioglitazone Hydrochloride)

Adult dose

This drug is administered orally once daily, regardless of meals. 1. Monotherapy This drug can be started at 15 mg once daily, and if the effect is insufficient, the dosage may be increased up to 30 mg once daily. 2. Combination therapy - Sulfonylurea: 15 mg once daily - Metformin: 15 mg once daily - Insulin: 15 mg once daily The maximum recommended dose is 30 mg once daily.

Child dose

There is no experience in children under 18 years, so use is not recommended.

This drug is used for the treatment of type 2 diabetes and only lowers blood sugar levels when insulin is present. This drug can put stress on the heart, so it should not be used in patients with congestive heart failure or a history of heart failure. During treatment, fluid retention may occur, leading to swelling and increasing the risk of worsening heart failure, so careful monitoring is necessary. If symptoms of heart failure, such as shortness of breath or swelling, occur during treatment, notify the healthcare provider immediately. This drug should not be used in patients with active bladder cancer or a history of bladder cancer, and if symptoms such as hematuria or urinary difficulties develop during treatment, inform the physician immediately. Since this drug may affect liver function, regular liver function tests should be conducted before and during treatment, and if liver dysfunction is suspected, consult a healthcare provider immediately. This drug may cause weight gain and edema, so careful management is necessary if there are changes in weight or symptoms of swelling. There is a risk of hypoglycemia, so when used in combination with insulin or other hypoglycemic agents, pay attention to symptoms of hypoglycemia, and dosage adjustments may be needed as necessary. Pregnant women or women who may become pregnant should consult a physician before taking this drug, and women of childbearing age should use appropriate contraceptive methods to prevent pregnancy. Elderly patients or those with impaired renal and liver function require closer monitoring when taking this drug. During treatment, adhere to the prescribed times and dosages, and do not double the dose the next day if a dose is missed. Regular checks of blood sugar and glycosylated hemoglobin should be performed to confirm blood sugar control. There may be drug interactions, so if taking other medications, inform the physician or pharmacist. This drug is not recommended for children as its safety and efficacy have not been established.

Serious side effects

Congestive heart failure, heart failure, edema (severe swelling), abnormal urination, rash, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory distress accompanied by cough and fever, jaundice (yellowing of the skin or eyes), systemic malaise, liver abnormalities, sudden and

Mild side effects

• Headache
• sinusitis
• myalgia
• pharyngitis
• abdominal distension
• weight gain
• hypoglycemia
• upper respiratory infection
• urinary tract infection
• diarrhea

This drug should be stored in a special container to protect it from light and air exposure, and should be kept away from damp places. The appropriate storage temperature is between 15 degrees and 30 degrees, and it is advisable to store it particularly around 25 degrees.

Appearance

White or almost white, convex cylindrical tablets

Package unit

30 tablets/PTP [10 tablets/PTP packaging X 3], 30 tablets/bottle, 100 tablets/bottle